Your browser doesn't support javascript.
loading
How Can the Typhoid Fever Surveillance in Africa and the Severe Typhoid Fever in Africa Programs Contribute to the Introduction of Typhoid Conjugate Vaccines?
Jeon, Hyon Jin; Im, Justin; Haselbeck, Andrea; Holm, Marianne; Rakotozandrindrainy, Raphaël; Bassiahi, Abdramane Soura; Panzner, Ursula; Mogeni, Ondari D; Seo, Hye Jin; Lunguya, Octavie; Jacobs, Jan; Okeke, Iruka N; Terferi, Mekonnen; Owusu-Dabo, Ellis; Dougan, Gordon; Carey, Megan; Steele, A Duncan; Kim, Jerome H; Clemens, John D; Andrews, Jason R; Park, Se Eun; Baker, Stephen; Marks, Florian.
Affiliation
  • Jeon HJ; Department of Medicine, University of Cambridge, United Kingdom.
  • Im J; International Vaccine Institute, Seoul, Republic of Korea.
  • Haselbeck A; International Vaccine Institute, Seoul, Republic of Korea.
  • Holm M; International Vaccine Institute, Seoul, Republic of Korea.
  • Rakotozandrindrainy R; International Vaccine Institute, Seoul, Republic of Korea.
  • Bassiahi AS; University of Antananarivo, Madagascar.
  • Panzner U; Institut Supérieur des Sciences de la Population, Université Ouaga II, Ouagadougou, Burkina Faso.
  • Mogeni OD; International Vaccine Institute, Seoul, Republic of Korea.
  • Seo HJ; International Vaccine Institute, Seoul, Republic of Korea.
  • Lunguya O; International Vaccine Institute, Seoul, Republic of Korea.
  • Jacobs J; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
  • Okeke IN; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp.
  • Terferi M; Department of Microbiology and Immunology, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Owusu-Dabo E; Faculty of Pharmacy, University of Ibadan, Nigeria.
  • Dougan G; Armauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia.
  • Carey M; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Steele AD; Department of Medicine, University of Cambridge, United Kingdom.
  • Kim JH; Bill & Melinda Gates Foundation, Seattle, Washington.
  • Clemens JD; Bill & Melinda Gates Foundation, Seattle, Washington.
  • Andrews JR; International Vaccine Institute, Seoul, Republic of Korea.
  • Park SE; icddr,b, Dhaka, Bangladesh.
  • Baker S; Fielding School of Public Health, University of California, Los Angeles.
  • Marks F; Korea University School of Medicine, Seoul.
Clin Infect Dis ; 69(Suppl 6): S417-S421, 2019 10 30.
Article in En | MEDLINE | ID: mdl-31665772
ABSTRACT

BACKGROUND:

The World Health Organization now recommends the use of typhoid conjugate vaccines (TCVs) in typhoid-endemic countries, and Gavi, the Vaccine Alliance, added TCVs into the portfolio of subsidized vaccines. Data from the Severe Typhoid Fever in Africa (SETA) program were used to contribute to TCV introduction decision-making processes, exemplified for Ghana and Madagascar.

METHODS:

Data collected from both countries were evaluated, and barriers to and benefits of introduction scenarios are discussed. No standardized methodological framework was applied.

RESULTS:

The Ghanaian healthcare system differs from its Malagasy counterpart Ghana features a functioning insurance system, antimicrobials are available nationwide, and several sites in Ghana deploy blood culture-based typhoid diagnosis. A higher incidence of antimicrobial-resistant Salmonella Typhi is reported in Ghana, which has not been identified as an issue in Madagascar. The Malagasy people have a low expectation of provided healthcare and experience frequent unavailability of medicines, resulting in limited healthcare-seeking behavior and extended consequences of untreated disease.

CONCLUSIONS:

For Ghana, high typhoid fever incidence coupled with spatiotemporal heterogeneity was observed. A phased TCV introduction through an initial mass campaign in high-risk areas followed by inclusion into routine national immunizations prior to expansion to other areas of the country can be considered. For Madagascar, a national mass campaign followed by routine introduction would be the introduction scenario of choice as it would protect the population, reduce transmission, and prevent an often-deadly disease in a setting characterized by lack of access to healthcare infrastructure. New, easy-to-use diagnostic tools, potentially including environmental surveillance, should be explored and improved to facilitate identification of high-risk areas.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Preventive Health Services / Typhoid Fever / Typhoid-Paratyphoid Vaccines Type of study: Incidence_studies / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2019 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Preventive Health Services / Typhoid Fever / Typhoid-Paratyphoid Vaccines Type of study: Incidence_studies / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2019 Type: Article Affiliation country: United kingdom